Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00390
Species: Homo sapiens
Position : chr13:28710000-28715000
Year: 2020
Title: 13q122 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  32384149
MONDO:
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: GM12878
CVCL ID: CVCL_7526
Cell Type: B lymphoblastoid cell
Cell Ontology ID: CL:0000945
Experiment Type: Enhancer activity assay, Chromatin interaction assay
High Throughput Method: ChIP-seq, RNA-seq, Hi-C, PLAC-seq, ATAC-seq, DNase-seq
Low Throughput Method: RT-RT-qPCR, FISH
About Target Gene
Target gene : FLT3
About TF
TF name : RUNX1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
RUNX1 AndrogenReceptor netpath 167
RUNX1 Organic cation transport reactome 9
RUNX1 RANKL netpath 84
RUNX1 Regulation of nuclear SMAD2/3 signaling pid 82
RUNX1 TGF_beta_Receptor netpath 220
RUNX1 Validated transcriptional targets of deltaNp63 isoforms pid 47
RUNX1 Pathways in cancer kegg 321
RUNX1 Chronic myeloid leukemia kegg 69
RUNX1 Acute myeloid leukemia kegg 53
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_00389 chr13:28710000-28715000 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_00391 chr13:28710000-28715000 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer